Brief: GemVax & KAEL receives patent

GemVax & KAEL

26/07/2018 08:26

July 26 (Reuters) - GemVax & KAEL Co Ltd  082270.KQ  :
    
    * Says it receives patent named Cell Penetrating Peptide,
and
conjugate and composition comprising the same

    
    
    Source text in Korean: https://goo.gl/EwgMnK
    Further company coverage:  082270.KQ 

 (Beijing Headline News)
 ((Beijing.HeadlineNews@thomsonreuters.com; Reuters Messaging:
Yinglan.Ma@thomsonreuters.com@reuters.net))